How Is Bipolar Disorder Diagnosed? Clinical Assessment Explained

Author: Ukrainian Psychological Hub · Published: October 9, 2026 · Editorial Policy

Bipolar disorder is diagnosed through a comprehensive clinical assessment of mood episodes across a person's lifetime. A clinician evaluates sustained changes in mood and energy, episode duration, the effects on behavior and functioning, family and treatment history, medical conditions, substances, and possible alternative explanations. The decisive question is whether there is sufficient evidence of a manic or hypomanic episode, alongside the other requirements of the relevant diagnostic category. No blood test, brain scan, symptom checklist, or online screening score can independently diagnose bipolar disorder. NIMH; NICE.

A person may first seek help during severe depression, anxiety, an episode of unusually high energy, or a crisis. Because hypomania may be remembered as unusually productive or pleasant rather than as illness, the clinical interview looks beyond the immediate complaint. A reliable evaluation connects present symptoms with earlier episodes, periods of usual functioning, observations from other people when appropriate, and changes over time. VA/DoD 2023.

For the broader diagnostic context, see Bipolar Disorder: Symptoms, Types, Diagnosis, and Treatment. This clinical assessment guide concentrates on what a qualified clinician actually evaluates.

What clinicians are trying to establish

Bipolar disorder is a group of clinically defined conditions characterized by particular patterns of mood episodes. Diagnosis uses a classification framework, most often DSM-5-TR in American clinical practice and ICD-11 in international settings. Assessment addresses the kind of episode, symptom combinations, length, severity, changes from baseline, functional impact, exclusion of competing causes, and longitudinal course. The diagnostic label is a clinical formulation intended to guide care and can be reconsidered when new historical evidence emerges. WHO ICD-11 clinical descriptions; VA/DoD guideline.

Bipolar I disorder requires at least one qualifying manic episode; a depressive episode is common but is not mandatory for this diagnosis. Bipolar II disorder requires at least one hypomanic episode and at least one major depressive episode, without a history of mania. Cyclothymic disorder involves a prolonged pattern of fluctuating symptoms below the full thresholds for hypomanic and depressive episodes. Other specified and unspecified bipolar-related categories cover clinically significant presentations that cannot be fully assigned to the preceding diagnoses. The exact category matters because mania, hypomania, and depressive episodes carry different clinical implications. NIMH; WHO.

Step 1: Identifying the reason for assessment and any immediate danger

The clinician first clarifies what prompted the appointment. Depression may be accompanied by a history of highly energized periods; a family member may describe unusually rapid speech, erratic financial decisions, marked irritability, or nights with very little sleep; or a patient may report abrupt changes after medication. The interviewer asks what was different from the person's ordinary behavior and when it began. When someone presents with depression, NICE specifically recommends asking about previous periods of overactivity or disinhibited behavior; a history lasting four days or more may prompt referral for specialist assessment. NICE recommendations 1.2.1–1.2.2.

Safety is assessed from the outset. Suspected severe mania, acute psychosis, suicidal intent, profound impairment of judgment, inability to meet basic needs, or danger to another person may require urgent evaluation and potentially hospital-based care. A normal-length outpatient interview should not delay emergency assistance in such circumstances. Risk assessment is individual and includes current symptoms, available support, and immediate threats, rather than treating a diagnostic label alone as proof of danger. VA/DoD diagnostic triage; NICE urgent referral guidance.

Step 2: Reconstructing a lifetime timeline of episodes

The diagnostic interview gathers a chronological psychiatric history. Clinicians ask when depressive periods began, whether any distinct periods of unusually elevated or irritable mood occurred, how energy and activity changed, how long the changes lasted, how often episodes recurred, and what happened between episodes. They explore sleep, goals, speech, thinking speed, distractibility, confidence, impulsive actions, and effects on work or family life. An episode must be established through its pattern, not inferred from one dramatic behavior. NICE full assessment.

Questions about the course are often very specific: Was the person energetic after three hours of sleep without feeling tired, or exhausted but unable to sleep? Did others notice a departure from usual behavior? Did the pattern persist for days? Was it linked to a substance, medication, illness, or major change in sleep? Was there excessive spending, sexual risk-taking, dangerous driving, or impaired judgment? What evidence remains from that period? The answers allow a clinician to distinguish a likely episode from isolated excitement, stress, ordinary mood variation, or a different psychiatric presentation. VA/DoD history checklist.

Historical reconstruction can be difficult. Someone may remember the emotional tone of a period but forget dates, sleep patterns, or consequences. Depression can dominate recall, while elevated periods may be remembered as successes. Previous hospital records, prescriptions, clinician notes, dated messages, personal journals, and calendars may assist. Where appropriate and with the patient's permission, reports from a partner, family member, or another person who knew the individual during the episode can corroborate changes. Collateral history enriches clinical evidence; another person's opinion is not a diagnosis. NICE recommendation 1.3.2.

Step 3: Evaluating mania, hypomania, and depression

What counts as a manic episode?

Under DSM-5-TR criteria used in US clinical settings, mania includes a distinct period of abnormally and persistently elevated, expansive, or irritable mood and increased activity or energy, typically lasting at least one week for most of the day nearly every day, or any duration if hospitalization is necessary. A qualifying constellation of additional symptoms is needed, along with marked impairment, need for hospitalization, or psychotic features. Symptoms may include decreased need for sleep, inflated self-esteem, increased or pressured speech, racing thoughts, distractibility, agitation or heightened goal-directed activity, and risky decisions. The clinician must also assess whether another cause better accounts for the episode. VA/DoD DSM-5-TR-oriented guidance; NIMH.

Mania is assessed by its severity and the change from a person's normal functioning. Someone can be unusually irritable rather than euphoric. Psychosis, when present during a qualifying mood episode, is particularly important to document. A person who feels energetic and works long hours has not necessarily experienced mania: the whole symptom constellation, duration, functional consequences, and possible alternative causes must support the conclusion. NIMH.

How is hypomania different?

A DSM-5-TR hypomanic episode involves a distinct sustained change in mood and increased activity or energy lasting at least four consecutive days, together with characteristic symptoms and an observable departure from usual functioning. The episode does not reach the level of marked impairment required for mania and does not require hospitalization. If psychotic features are present, the episode is manic rather than hypomanic. A hypomanic period can be positively experienced or difficult to recognize retrospectively, but it must still satisfy the clinical criteria. VA/DoD; NIMH.

The distinction is crucial for determining bipolar I versus bipolar II. Bipolar II often entails substantial depressive burden and functional difficulty. The absence of full mania does not make the condition inconsequential. A clinician must ask whether an apparent hypomanic episode ever crossed into marked impairment, psychosis, or hospitalization and whether its timing and symptom profile actually met criteria. NIMH.

What about depressive episodes?

A major depressive episode generally involves at least two weeks of an established symptom pattern, including depressed mood or loss of interest and associated changes in sleep, appetite, energy, concentration, psychomotor activity, self-worth, or suicidal thinking, with clinical distress or impairment. Depression during bipolar disorder can resemble unipolar depression. The presence of depressive symptoms alone does not establish whether the depressive episode belongs to a bipolar course. Clinicians therefore revisit the lifetime history of mania and hypomania even when someone currently appears exclusively depressed. NIMH; NICE.

Mixed features and rapid cycling

Mixed features means that qualifying symptoms associated with the opposite mood pole occur during the current mood episode. It is a clinical specifier requiring careful assessment, particularly when agitation or suicidal thinking is present. Rapid cycling is a course specifier involving at least four qualifying mood episodes in twelve months, with rules concerning separation or changes in polarity. Neither term is synonymous with ordinary mood swings over a few hours. These distinctions prevent daily emotional variability from being misclassified as repeated episodes. WHO ICD-11 descriptions; NIMH.

Step 4: Assessing functioning, sleep, and circumstances

Clinicians evaluate work, education, finances, relationships, personal care, social interactions, and safety across possible episodes. Functional consequences help establish the severity and clinical meaning of the presentation. Changes that seem productive in the short term may have broader consequences, while some symptoms may create significant private distress that is not immediately apparent. A history of hospitalization, disciplinary action, a sudden change in spending, or a relationship crisis can be relevant as corroborating evidence when interpreted in context. NICE.

Sleep is evaluated as both a symptom and a possible contributor. Reduced need for sleep means a person sleeps much less than usual without corresponding tiredness, while insomnia usually includes difficulty sleeping and often fatigue. Shift work, caregiving, substances, circadian disruption, and sleep disorders can produce overlapping complaints. A sleep log with changes in energy, activities, and mood can clarify the pattern without making the log itself a diagnostic test. VA/DoD.

Family history may increase clinical suspicion, particularly with a first-degree relative who has bipolar disorder. The assessor also reviews prior depressive episodes, age at onset, psychotic symptoms, previous treatment responses, anxiety, substance use, and stressful life events. Each item contributes to the overall formulation, and none independently proves the diagnosis. VA/DoD clinical history guidance.

Step 5: Ruling out medical, medication-related, and substance-related explanations

Medical review includes chronic illnesses, neurologic and endocrine symptoms, previous medical events, medications, supplements, and alcohol or other substance exposure. The clinician considers whether intoxication, withdrawal, a medication reaction, or a physical illness could better explain unusual energy, agitation, insomnia, or other symptoms. History and physical examination may reveal reasons for targeted additional tests. NIMH; VA/DoD.

The 2023 VA/DoD primary-care evaluation includes medication reconciliation, a mental status and physical examination, and an appropriate basic laboratory assessment that may include thyroid-stimulating hormone, complete blood count, comprehensive metabolic panel, and urine drug screening. Neuroimaging and advanced neurologic testing are reserved for relevant abnormal findings rather than ordered routinely to prove a bipolar diagnosis. A normal blood panel does not exclude bipolar disorder, and an abnormal result must be interpreted for its actual medical significance. VA/DoD pocket card.

Medication-related activation deserves particular attention. A patient may develop increased energy, agitation, reduced sleep, or mood elevation in temporal association with antidepressants, stimulants, corticosteroids, or other agents. Clinicians distinguish a possible medication effect from a spontaneous qualifying mood episode by examining timing, persistence, co-occurring symptoms, and diagnostic criteria. A reaction to a drug should prompt careful clinical review, not an automatic assumption of a lifetime bipolar diagnosis. Any medication change should be discussed with the prescribing professional. VA/DoD; NICE.

Step 6: Differential diagnosis and co-occurring conditions

Bipolar depression versus unipolar depression

When a person presents with depression, clinicians ask about any previous convincing manic or hypomanic episodes. Several characteristics, including early onset, repeated depressive episodes, family history, and certain treatment-related changes, can increase the need for inquiry but do not individually distinguish the disorders with certainty. A complete longitudinal history is essential because the depressive symptoms themselves may overlap substantially. NIMH; VA/DoD.

Bipolar disorder, ADHD, and borderline personality disorder

Impulsivity, distractibility, irritability, emotional dysregulation, and sleep difficulties can occur in more than one condition. ADHD is evaluated through developmental and cross-setting history, including symptoms outside discrete mood episodes. Borderline personality disorder is evaluated through its characteristic longer-term patterns involving identity, relationships, emotional reactivity, and related features. Bipolar disorder requires evidence of mood episodes meeting specific criteria. Overlap and comorbidity are possible, so clinicians assess the complete pattern rather than treating any single symptom as decisive. Differential diagnostic review; Bayes and colleagues.

Psychosis, anxiety, OCD, and sleep conditions

When psychotic symptoms occur, the clinician determines their timing relative to mood episodes and considers schizophrenia-spectrum and schizoaffective disorders. Anxiety and obsessive-compulsive symptoms may be independent, episode-associated, or co-occurring. Intrusive thoughts and compulsions require a different type of assessment from expansive mood and increased goal-directed activity. A broader history also evaluates sleep disorders and stress-related presentations. NIMH; NICE.

The English Hub's existing articles on OCD versus bipolar disorder and OCD occurring with bipolar disorder examine these overlaps in detail. During an individual assessment, the clinician determines which diagnostic criteria are actually met and how co-occurring difficulties affect treatment planning.

Do screening tools such as the MDQ diagnose bipolar disorder?

No. The Mood Disorder Questionnaire (MDQ), Hypomania Checklist (HCL-32), and Bipolar Spectrum Diagnostic Scale (BSDS) are screening instruments, designed to flag information for further evaluation. They cannot establish whether symptoms formed a qualifying episode, whether another condition explains them, or whether the required functional and exclusion criteria have been satisfied. Structured and semistructured interviews may aid systematic assessment, but their interpretation remains part of professional clinical judgment. Hirschfeld et al.; screening meta-analysis.

The separate instrument review, Bipolar Disorder Screening Tests: MDQ, HCL-32, and Their Limitations, examines their performance and practical limits in more detail.

A meta-analysis of 21 studies found pooled MDQ sensitivity of 0.62 and specificity of 0.85 at standard or modified cutoff 7. In studies excluding people with an already known bipolar diagnosis, sensitivity was substantially lower, at 0.37. The test's accuracy varies with clinical setting, population, subtype, and threshold; a positive result is not a diagnosis, while a negative result cannot safely exclude bipolar disorder. These study-level figures should not be used to calculate one person's certainty from an online score. Wang et al., 2015.

Guidelines differ in their recommended role for screening. The 2023 VA/DoD primary-care pathway includes a validated screening instrument within broader evaluation, whereas NICE recommendation 1.2.3 advises against using questionnaires in primary care to identify bipolar disorder in adults. This disagreement concerns the utility of screening in particular contexts; both recognize that diagnosis requires clinical assessment. It is appropriate to discuss an online result with a clinician without assuming that a score establishes or rules out the condition.

How is the final diagnosis reached?

The clinician integrates the lifetime timeline, episode criteria, medical and psychiatric assessment, family and treatment history, functional evidence, collateral information when available, and differential diagnosis. They assess whether the evidence fits bipolar I, bipolar II, cyclothymia, another specified presentation, a different disorder, or an unresolved provisional formulation. The reasoning should distinguish established episodes from symptoms that suggest a possibility but remain uncertain. VA/DoD diagnostic pathway; WHO clinical descriptions.

The diagnostic criteria that distinguish subtypes are developed in Bipolar I vs Bipolar II: Differences in Episodes, Diagnosis, and Course. The assessment here focuses on reconstructing a reliable history and differential evaluation.

A clear manic episode with reliable history may permit relatively prompt diagnosis. When the only recorded presentation is depression and past hypomania is unclear, more appointments, records, collateral observations, or prospective symptom monitoring may be necessary. Diagnostic revision after new evidence is part of careful clinical practice. The person should be able to ask which criteria are satisfied, what competing explanations remain, and what further information would materially change the conclusion. NIMH; NICE.

Considerations for particular populations

Children and teenagers

Assessment in young people requires developmental expertise because irritability, fluctuating behavior, ADHD, sleep disturbances, trauma, and other conditions may complicate recognition. NICE recommends specialist assessment and intensive prospective longitudinal monitoring before assigning a pediatric bipolar diagnosis, involving parents or carers and taking account of educational and social functioning. Adult diagnostic shortcuts and online screening thresholds should not replace this process. NICE recommendations 1.11.1–1.11.7.

Older adults and late-onset symptoms

A first apparent episode of mania in later adulthood calls for thorough evaluation of neurologic or medical contributors, medication effects, substance exposure, cognition, and earlier mood history. Additional examination or investigation is directed by the clinical findings. The presence of an unusual symptom late in life is a reason to broaden assessment, not to presume a particular diagnosis without evidence. VA/DoD; NICE.

Pregnancy and postpartum assessment

Pregnancy and the postpartum period require attention to sleep disruption, obstetric and psychiatric history, medication exposure, and the safety of the parent and infant. Acute severe mood symptoms, psychosis, or seriously impaired judgment during the postpartum period merit urgent specialized assessment. Decisions about medication before, during, or after pregnancy require coordinated professional care rather than unsupervised changes. NICE guideline.

Preparing for an appointment

A dated timeline of depression, elevated mood, irritability, energy, sleep, and relevant behaviors can make the interview more precise. Note what other people observed, how long the changes lasted, whether daily functioning was affected, and what happened between episodes. Bring available records of previous diagnoses and treatment, current prescriptions and supplements, significant medical conditions, substance exposure, and family psychiatric history. With consent, a trusted person may help describe an earlier episode that is difficult to recall. NICE; VA/DoD.

Useful questions include: Which episode criteria appear to be met? Was the elevated period mania or hypomania, and on what basis? What medical and psychiatric alternatives are being examined? What information is missing? Is the current formulation provisional? How will symptoms be monitored, and what signs require faster follow-up? These questions encourage collaborative and transparent care without attempting to replace professional assessment.

What happens after diagnosis?

After the assessment, the clinician discusses what has been established, current symptoms and safety, and a care plan matched to the relevant phase of illness. Acute mania, bipolar depression, and maintenance treatment have different clinical aims and evidence bases. Treatment decisions may include medication, structured psychological interventions, support for sleep and routines, relapse prevention, and treatment of co-occurring disorders. The person's own priorities and previously effective or poorly tolerated interventions are relevant. CANMAT/ISBD evidence update; VA/DoD maintenance guidance.

Lithium, certain antipsychotics, lamotrigine, valproate, and antidepressants have distinct indications and safety considerations across different phases and populations. Monitoring may involve physical health, laboratory testing, interactions, adverse effects, or reproductive risks depending on the medication. The diagnostic visit is an opportunity to clarify these issues with a prescribing professional, never a reason to independently begin, stop, or adjust medication. NICE treatment guidance; CANMAT/ISBD.

When to seek urgent help

Immediate safety takes precedence over diagnostic certainty. If someone has suicidal intent or imminent danger of serious harm, severe mania with unsafe decisions, psychosis with major safety concerns, or an inability to care for basic needs, seek emergency medical assistance or the local emergency service. Rapidly escalating symptoms and prolonged severe sleep loss with impaired judgment merit prompt clinical contact. A supportive person can help arrange care when it is safe and appropriate. VA/DoD safety assessment; NICE urgent assessment.

Frequently asked questions

Can a primary care clinician diagnose bipolar disorder?

A primary care professional can begin assessment, review medical and medication-related causes, evaluate safety, and arrange further evaluation. Suspected mania, severe depression, complex differential diagnosis, or immediate safety concerns warrant appropriate specialist or emergency involvement. Local pathways and available expertise determine the next step. VA/DoD; NICE.

Is there a blood test, MRI, or genetic test for bipolar disorder?

There is no routinely accepted laboratory, imaging, or genetic test that diagnoses bipolar disorder on its own. Clinical tests may be used to investigate other illnesses or inform treatment safety. Research on biomarkers does not make them established diagnostic substitutes for an episode history and professional evaluation. NIMH; VA/DoD.

Can bipolar II be diagnosed without mania?

Yes. Bipolar II requires hypomania and a major depressive episode, with no history of full mania. Establishing a true hypomanic episode still requires assessment of symptoms, duration, observable change, exclusion of competing causes, and clinical context. NIMH.

Can bipolar disorder be diagnosed while someone is depressed?

Yes, if a reliable prior history supplies the necessary manic or hypomanic episode evidence. Depression alone does not identify bipolar disorder, which is why clinicians ask about earlier changes in energy, mood, activity, and sleep. NICE.

Does a positive MDQ result prove bipolar disorder?

No. Screening questionnaires have false positives and false negatives, and their performance varies by context. They can provide topics for further discussion, but a diagnosis requires a clinical interview and longitudinal evaluation. Wang et al..

Do mood swings several times per day mean rapid-cycling bipolar disorder?

No. Rapid cycling has a specific definition involving qualifying mood episodes over a year. Daily emotional fluctuations may require assessment but are not themselves evidence of the required episodes. NIMH; WHO.

Does having a parent with bipolar disorder mean I will receive the diagnosis?

No. Family history is relevant to risk and clinical suspicion, but diagnosis depends on the individual's own episodes and overall assessment. VA/DoD.

Can a previous diagnosis change?

Yes. New records, longer follow-up, observations from others, and additional evidence about medications or medical conditions may change the formulation. Ask the clinician what new evidence affected the conclusion and how it changes care. NICE.

Related Articles

Bipolar Disorder: Symptoms, Types, Diagnosis, and Treatment — foundational guide to the clinical condition and categories.

Bipolar Disorder Screening Tests: MDQ, HCL-32, and Their Limitations — dedicated evidence on screening and test limitations.

Bipolar I vs Bipolar II: Differences in Episodes, Diagnosis, and Course — criteria separating mania, hypomania, and the two diagnoses.

OCD vs Bipolar Disorder: What Is the Difference? — differences between obsessions, compulsions, and mood episodes.

OCD and Bipolar Disorder: What Is the Connection? — co-occurring symptoms and assessment considerations.

Neuroticism and Bipolar Disorder: Associations, State Effects, and Limits — interpreting personality-related observations.

References

Bayes, A. J., et al. (2016). Differentiating the bipolar disorders from borderline personality disorder. Acta Psychiatrica Scandinavica, 133(3), 187–195. https://doi.org/10.1111/acps.12509.

Carvalho, A. F., et al. (2015). Screening for bipolar spectrum disorders: A comprehensive meta-analysis of accuracy studies. Journal of Affective Disorders. PubMed PMID 25451435.

Hirschfeld, R. M. A., et al. (2000). Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire. American Journal of Psychiatry, 157(11), 1873–1875. https://doi.org/10.1176/appi.ajp.157.11.1873.

Keramatian, K., Chithra, N. K., & Yatham, L. N. (2023). The CANMAT and ISBD guidelines for the treatment of bipolar disorder: Summary and a 2023 update of evidence. Focus, 21(4), 344–353. https://doi.org/10.1176/appi.focus.20230009.

National Institute for Health and Care Excellence. (2014; current online guidance). Bipolar disorder: Assessment and management (CG185). Recommendations.

National Institute of Mental Health. (n.d.). Bipolar disorder. Official publication.

U.S. Department of Veterans Affairs & U.S. Department of Defense. (2023). Management of bipolar disorder: Diagnosis and triage, clinical practice guideline pocket card. Official PDF.

Wang, H. R., Woo, Y. S., Ahn, H. S., Ahn, I. M., Kim, H. J., & Bahk, W.-M. (2015). The validity of the Mood Disorder Questionnaire for screening bipolar disorder: A meta-analysis. Depression and Anxiety, 32(7), 527–538. https://doi.org/10.1002/da.22374.

World Health Organization. (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. Official publication.